z-logo
open-access-imgOpen Access
Sodium-glucose co-transporter 2 inhibitors and diabetic retinopathy: insights into preservation of sight and looking beyond
Author(s) -
Sejal Lahoti,
Mouhamed Nashawi,
Omar Sheikh,
David Massop,
Mahnoor Mir,
Robert Chilton
Publication year - 2020
Publication title -
cardiovascular endocrinology and metabolism
Language(s) - English
Resource type - Journals
SCImago Journal Rank - 0.498
H-Index - 8
ISSN - 2574-0954
DOI - 10.1097/xce.0000000000000209
Subject(s) - medicine , diabetes mellitus , diabetic retinopathy , clinical trial , diabetic nephropathy , retinopathy , adverse effect , type 2 diabetes , nephropathy , disease , empagliflozin , type 2 diabetes mellitus , intensive care medicine , pharmacology , endocrinology

The content you want is available to Zendy users.

Already have an account? Click here to sign in.
Having issues? You can contact us here